Parathyroid hormone-related protein (PTH-rP)-associated hypercalcemia in a patient with an atypical chronic lymphocytic leukemia.

[1]  T. Guise.  Parathyroid hormone‐related protein and bone metastases , 1997, Cancer.

[2]  M. Rogers,et al.  Overview of bisphosphonates , 1997, Cancer.

[3]  G. Roodman.  Mechanisms of bone lesions in multiple myeloma and lymphoma , 1997, Cancer.

[4]  W. Rankin,et al.  Parathyroid hormone‐related protein and hypercalcemia , 1997, Cancer.

[5]  D. Catovsky,et al.  Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12 , 1997, British journal of haematology.

[6]  Robert Vlietinck,et al.  Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases , 1997, British journal of haematology.

[7]  M. James,et al.  11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. , 1997, Blood.

[8]  Martin Tj.  Actions of Parathyroid Hormone–Related Peptide and Its Receptors , 1996 .

[9]  T. Martin,et al.  Parathyroid hormone‐related protein in hypercalcaemia associated with haematological malignancy , 1996, British journal of haematology.

[10]  J. Knochel,et al.  Hypercalcemia and electrolyte disturbances in malignancy. , 1996, Hematology/oncology clinics of North America.

[11]  D. Catovsky,et al.  Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients , 1996, British journal of haematology.

[12]  C. Fegan,et al.  Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. , 1995, Leukemia.

[13]  M. Keating,et al.  PARATHYROID HORMONE RELATED PROTEIN IN HYPERCALCAEMIA IN CLL , 1995, British Journal of Haematology.

[14]  J. Kanis,et al.  Consequences of neoplasia induced bone-resorption and the use of clodronate (review). , 1994, International journal of oncology.

[15]  M. Keating,et al.  Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation. Case report and review. , 1994, American journal of clinical oncology.

[16]  D. Meseure,et al.  Hypercalcaemia in B cell chronic lymphocytic leukaemia , 1994, British journal of haematology.

[17]  J. Seymour,et al.  Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. , 1993, Blood.

[18]  T. Martin,et al.  Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia , 1993, The Lancet.

[19]  J. Bilezikian.  Management of acute hypercalcemia. , 1992, The New England journal of medicine.

[20]  H. Gralnick,et al.  Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. , 1989, Journal of clinical pathology.

[21]  E. Chen,et al.  A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. , 1987, Science.

[22]  S. O'brien,et al.  Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. , 1995, Blood.